|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2001-12-12
|
|
pubmed:abstractText |
Neuroendocrine molecules are now believed to play a significant role in the progression of human prostate cancer (CaP), especially in the androgen-independent stage.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12 Suppl 2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
S27-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11762347-Androgens,
pubmed-meshheading:11762347-Blotting, Western,
pubmed-meshheading:11762347-Cyclic AMP,
pubmed-meshheading:11762347-Disease Progression,
pubmed-meshheading:11762347-Forskolin,
pubmed-meshheading:11762347-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:11762347-Humans,
pubmed-meshheading:11762347-Male,
pubmed-meshheading:11762347-Prostatic Neoplasms,
pubmed-meshheading:11762347-Receptors, Neuropeptide Y,
pubmed-meshheading:11762347-Tumor Cells, Cultured
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Expression of neuropeptide Y receptors in human prostate cancer cells.
|
|
pubmed:affiliation |
Center for Endocrinologial Oncology Institute of Endocrinology University of Milan, Italy. paolo.magni@unimi.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
